Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bortezomib with Melphalan and Auto-SCT in Multiple Myeloma
NCT00793650Phase 2Terminated
- Sponsor
- Emory University
- Start
- May 2005
- Primary completion
- Oct 2009
- Modality
- Small Molecules, Modified Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of bortezomib in multiple myeloma (MM), sponsored by Emory University. Started May 2005; status: terminated.
02
Drugs
bortezomib
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT00793650.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00793650.